ALTEOGEN Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Soon-Jae Park
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 19.8% |
| Management average tenure | 2.3yrs |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
ALTEOGEN (KOSDAQ:196170) Has Debt But No Earnings; Should You Worry?
Feb 29
ALTEOGEN Inc.'s (KOSDAQ:196170) Has Found A Path To Profitability
Apr 13Is Weakness In ALTEOGEN Inc. (KOSDAQ:196170) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 18
Do Insiders Own Lots Of Shares In ALTEOGEN Inc. (KOSDAQ:196170)?
Dec 27CEO
Soon-Jae Park
no data
Tenure
Dr. Soon-Jae Park, Ph D., serves as the Chief Executive Officer of ALTEOGEN Inc. He has several years of experience in R&D of biomedicine. He served as the Executive Officer at BINEX Co., Ltd.He started w...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | no data | no data | 19.78% ₩ 1.9t | |
| CFO & Executive VP | 2.3yrs | no data | no data | |
| CTO, Executive VP and Head of R&D Center | no data | no data | no data | |
| Chief Scientific Officer | no data | no data | 0.79% ₩ 75.2b | |
| VP & Head of Research Planning | no data | no data | 0.40% ₩ 38.3b | |
| Senior Vice President of Management Support Group | 2.3yrs | no data | no data | |
| Senior VP & Corporate Alliance Officer (CAO) | 4.3yrs | no data | no data | |
| Senior VP & Head of New Drug Development | no data | no data | no data | |
| Chief Business Development Officer | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Management: A196170's management team is considered experienced (2.3 years average tenure).